[Malignant mesothelioma of the pleura: place of surgery].
Giudicelli
R
R
Hôpital de la Timone, Hôpital Sainte-Marguerite, Marseille.
Regnard
J-F
JF
Astoul
P
P
Ruffie
P
P
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004322:Drainage; D005971:Glutamates / Q000008:administration & dosage; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008197:Lymph Node Excision; D008279:Magnetic Resonance Imaging; D008654:Mesothelioma / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D000068437:Pemetrexed; D010994:Pleura / Q000473:pathology / Q000601:surgery; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D011013:Pneumonectomy; D011182:Postoperative Care; D013906:Thoracoscopy; D013997:Time Factors
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine; D002945:Cisplatin